JNJ-64155806

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-64155806, covering 2017-09-01 to 2017-09-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Interaction Between JNJ-64155806 and Ethinylestradiol/Drospirenone in Healthy Females [Phase 1]

See pricing